Cipla shareholders approve FY26 results and auditor appointment
Cipla Limited reported record revenue of INR 28,163 Cr and a PAT of INR 3,879 Cr for FY26. At the 90th AGM held on June 25, 2026, shareholders approved the financial statements, declared a dividend, and appointed M/s B S R & Co. LLP as statutory auditors. All six resolutions were passed with overwhelming majority.

*this image is generated using AI for illustrative purposes only.
Cipla Limited reported its highest-ever yearly revenue of INR 28,163 Cr for the financial year ended March 31, 2026, achieving a Profit After Tax (PAT) of INR 3,879 Cr with a margin of 13.8% and an EBITDA of INR 5,925 Cr with a 21.0% margin. The company maintained a strong net cash position of over $1 Bn, with total cash increasing to INR 11,140 Cr in FY26 from INR 10,807 Cr in the previous year. Total debt was reported at INR 614 Cr, and the R&D expense was 7% of revenue.
The 90th Annual General Meeting (AGM) was held on June 25, 2026, through video conferencing. Shareholders appointed M/s B S R & Co. LLP, Chartered Accountants, as its Statutory Auditors for a term of five years effective from the conclusion of the AGM. The appointment follows the completion of the second term of the previous auditors, M/s Walker Chandiok & Co. LLP. The resolutions passed included the adoption of the audited standalone and consolidated financial statements for FY26, the declaration of a dividend, and the re-appointment of Mr Adil Zainulbhai as a director liable to retire by rotation.
Business Performance
Cipla delivered a robust performance across its key markets. The One India segment reported revenue of INR 12,680 Cr, an increase of 9% year-on-year, delivering double-digit growth across three segments in Q4 FY26. North America revenue stood at $780 Mn, boosted by the approval for the first AB-rated gVentolin with Complex Generic Technology (CGT). The One Africa segment recorded $483 Mn, up 7% YoY, while Emerging Markets & Europe crossed the $400 Mn benchmark with $405 Mn in revenue.
Financial Discipline
The company has set a long-term goal to achieve Net Zero by 2050 and reported an 82% reduction in scope 1 and scope 2 GHG emissions compared to the FY2019-2020 baseline. It achieved 2.6 times water positivity and 84% renewable electricity usage. The meeting was presided over by Dr Y K Hamied, Non-Executive Chairman, and attended by 92 participants.
| Resolution Description | Votes In Favor | Votes Against | % In Favor |
|---|---|---|---|
| Adopt standalone financial statements FY26 | 654,195,724 | 1,827,354 | 99.72% |
| Adopt consolidated financial statements FY26 | 654,196,863 | 1,826,120 | 99.72% |
| Declare dividend on equity shares | 656,548,699 | 1,046 | 99.99% |
| Re-appoint Mr Adil Zainulbhai as director | 647,221,617 | 9,287,625 | 98.58% |
| Appoint Statutory Auditors and fix remuneration | 656,506,124 | 3,117 | 99.99% |
| Ratify Cost Auditor remuneration for FY27 | 656,505,921 | 3,281 | 99.99% |
Historical Stock Returns for Cipla
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.15% | +1.26% | +5.72% | -3.53% | -2.63% | +48.92% |
How will Cipla utilize its strong net cash position of over $1 Bn to drive future growth?
What impact will the approval of the first AB-rated gVentolin with CGT have on North American market share?
What are the strategic plans to sustain double-digit growth in the One India segment?































